"False"
Umeå universitet
printicon
Huvudmenyn dold.

Remigius Gröning

Kontakt

E-post
remigius.groning@umu.se
Telefon

Verksam vid

Anknytning
Anknuten som doktorand till Institutionen för klinisk mikrobiologi
Plats
6F och 6M, Universitetssjukhuset by 6 o 24 Umeå universitet, 901 85 Umeå
SARS-CoV-2 and the human immune system: disease, vaccination, and treatment
Umeå University medical dissertations, 2321
Gröning, Remigius
Intravenous immunoglobulin therapy for COVID-19 in immunocompromised patients: a retrospective cohort study
International Journal of Infectious Diseases, Elsevier 2024, Vol. 144
Gröning, Remigius; Walde, Jonatan; Ahlm, Clas; et al.
Immune response to SARS-CoV-2 mRNA vaccination in multiple sclerosis patients after rituximab treatment interruption
Frontiers in Immunology, Frontiers Media S.A. 2023, Vol. 14
Gröning, Remigius; Dernstedt, Andy; Ahlm, Clas; et al.
Structural and mechanistic basis of neutralization by a pan-hantavirus protective antibody
Science Translational Medicine, American Association for the Advancement of Science (AAAS) 2023, Vol. 15, (700)
Mittler, Eva; Serris, Alexandra; Esterman, Emma S.; et al.
At-home sampling to meet geographical challenges for serological assessment of SARS-CoV-2 exposure in a rural region of northern Sweden, March to May 2021: a retrospective cohort study
Eurosurveillance, European Centre for Disease Control and Prevention (ECDC) 2023, Vol. 28, (13)
Wigren, Julia; Vikström, Linnea; Rosendal, Ebba; et al.
Serine protease inhibitors restrict host susceptibility to SARS-CoV-2 infections
mBio, American Society for Microbiology 2022, Vol. 13, (3)
Rosendal, Ebba; Mihai, Ionut Sebastian; Becker, Miriam; et al.
Elevated plasma levels of NET components in men with severe COVID-19 correlates to increased amounts of IL-18
Backman, Emelie; Gröning, Remigius; Lind, Alicia; et al.
Variable immune response to SARS-CoV-2 mRNA vaccination in multiple sclerosis after rituximab treatment interruption
Gröning, Remigius; Dernstedt, Andy; Gardfjäll, Jenny; et al.
Visa publikationer i DiVA

Forskargrupper

Gruppmedlem
Forskning om Covid-19
Mattias Forsell Lab